An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples